메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Prof. Mike Chan and Leigh Steinberg Launch "Concussion" Book at Super Bowl Brain Health Summit 2026

SAN FRANCISCO, Feb. 27, 2026 -- European Wellness Biomedical Group, through its education division European Wellness Academy, is pleased to announce the official launch of "Concussion: The Hidden Trauma in Contact Sports and the NFL," co-authored by legendary NFL sports agent Leigh Steinberg and regenerative medicine pioneer Prof. Mike Chan, at the Brain Health Summit in San Francisco. The launch marked a defining moment in the global conversation surrounding concussion awareness, athlete safety, and long-term neurological health. Held during Steinberg's 39th Annual S
- 황정호 기자
- 2026-02-27 18:04
WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform

SHANGHAI, Feb. 27, 2026 -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. Earendil Labs is an AI-powered biotech company focused on researching and developing next-generation innovative biologics for the treatment of autoimmune diseases, cancer, and other conditions with unmet medica
- 김갑성 기자
- 2026-02-27 17:11
Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform

WILMINGTON, Del., Feb. 27, 2026 -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. WuXi XDC Cayman Inc. (stock code: 2268.HK) is a globally recognized contract research, development, and manufacturing organization (CRDMO) specializing in bioconjugates. The company offers a wide range of innovative conjugation and payload-linker technologies to fac
- 김갑성 기자
- 2026-02-27 15:00
Medit Announces "Glow Together" International Women's Day Campaign

SEOUL, South Korea, Feb. 27, 2026 -- Medit, a global provider of digital dentistry solutions, today announced that the "Glow Together" campaign will begin this March. The 'Glow Together' initiative began with small steps taken by the female employees of Medit. Light becomes more powerful when it is shared. Created in the spirit of International Women's Day, Glow Together is designed to spark connection across the dental community—and to translate participation into meaningful, real-world care beyond the clinic. While inspired by International Women's Day and t
- 김갑성 기자
- 2026-02-27 13:00
ASEAN Foundation introduced CALM MRI: Children and the No Longer Scary Machine

SINGAPORE, Feb. 27, 2026 -- The ASEAN Foundation organized the regional programme "CALM MRI – Fear to Confidence: Learning through Play with LEGO MRI Kits Programme", implemented across Indonesia and Singapore. The initiative serves as a platform to present the programme's outcomes, which aim to help children better understand Magnetic Resonance Imaging (MRI) procedures through a play-based learning approach. Designed to reduce anxiety and build familiarity, CALM MRI introduces children to the MRI process using specially designed LEGO® MRI kits. By transforming a
- 김갑성 기자
- 2026-02-27 12:39
Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction

SUZHOU, China, Feb. 27, 2026 -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. 20253180071). This represents a core signal of the company's strategic transformation implementation and accelerated domestic substitution layout, and is expected to become an important driver for its valuation repair, warranting close attention. From a market logic perspective, the approval of this product
- 김갑성 기자
- 2026-02-27 10:49
Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026

SINGAPORE, Feb. 27, 2026 -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the company's clinically approved laser portfolio across two of Asia's most highly regulated aesthetic markets. "The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is
- 김갑성 기자
- 2026-02-27 10:33
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

[ 메디채널 김갑성 기자 ] TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 27, 2026 -
- 김갑성 기자
- 2026-02-27 08:00
ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

SUZHOU, China, Feb. 27, 2026 -- Intravesical BCG is the standard of care (SOC) for BCG-naïve high-risk non-muscle-invasive bladder cancer (NMIBC) patients. However, the scarcity of BCG products has become a global phenomenon, and coupled with the side effects of BCG therapy itself, means that a substantial number of patients cannot access effective BCG treatment. Therefore, it is essential to seek better alternative therapies to BCG in order to meet clinical needs. Based on this, ImmVira Group is further expanding the clinical trial of its core oncolytic virus product, MVR-T3011—
- 김갑성 기자
- 2026-02-27 08:00
메디트, 세계 여성의 날 기념 'Glow Together' 캠페인 전개

서울, 대한민국 2026년 2월 26일 -- 디지털 덴티스트리 솔루션 분야의 글로벌 기업 메디트(Medit)는 오는 3월, 세계 여성의 날을 기념하는 글로벌 캠페인 'Glow Together'를 시작한다고 밝혔다. 'Glow Together'는 메디트의 여성 임직원들이 작은 실천에서 출발해, 나눌수록 더욱 강해지는 '빛'의 의미를 확장하자는 취지에서 시작됐다. 세계 여성의 날의 정신을 바탕으로 기획된 이번 캠페인은 전 세계 치과 커뮤니티 간의 연결을 촉진하고, 참여가 실제 사회적 가치로 이어지도록 설계됐다. 여성의 영향력에서 영감을 받았지만, 'Glow Together'는 성별과 관계없이 목적 있는 행동에 함께하고자 하는 모든 치과 전문인을 대상으로 진행된다. 캠페인 세부 내용, 참여 자격 및 등록 방법은 아래 페이지에서 확인할 수 있다.https://www.medit.com/glow_together/ 함께 나누는 빛에서 시작된 'Glow Together' 캠페인 'Glow Together'는 메디트 여성 구성원들의 내부 논의에서 출발했다. 작은 행동이라도 함께할
- 김갑성 기자
- 2026-02-27 08:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 00시 40분